Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015, Article ID 240407, 9 pages
http://dx.doi.org/10.1155/2015/240407
Research Article

Use of Dried Plasma Spots for HIV-1 Viral Load Determination and Drug Resistance Genotyping in Mexican Patients

1Unidad de Investigación Médica en Enfermedades Infecciosas y Parasitarias, UMAE Hospital de Pediatría, CMN Siglo XXI, Instituto Mexicano del Seguro Social (IMSS), Avenida Cuauhtémoc 330, Colonia Doctores, 06720 Mexico City, DF, Mexico
2Department of Pediatric Infectious Diseases, Hospital Infantil de México Federico Gómez, Dr. Marquez 162, Colonia Doctores, 06720 Mexico City, DF, Mexico
3Hospital de Infectología, UMAE Centro Medico Nacional “La Raza”, Instituto Mexicano del Seguro Social (IMSS), Avenida Jacarandas Esquina Vallejo S/N, Colonia La Raza, 02990 Mexico City, DF, Mexico

Received 8 September 2015; Accepted 19 November 2015

Academic Editor: Lucia Lopalco

Copyright © 2015 Juan Pablo Rodriguez-Auad et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. UNAIDS and WHO, “UNAIDS Report on the Global Aids Epidemic-2013,” 2013.
  2. WHO, UNICEF, and UNAIDS, “Towards universal access: scaling up priority HIV/AIDS interventions in the health sector,” Progress Report, 2010. View at Google Scholar
  3. S. D. Reid, S. J. Fidler, and G. S. Cooke, “Tracking the progress of HIV: the impact of point-of-care tests on antiretroviral therapy,” Clinical Epidemiology, vol. 5, no. 1, pp. 387–396, 2013. View at Publisher · View at Google Scholar · View at Scopus
  4. J. M. Raboud, M. R. Loutfy, D. Su et al., “Regional differences in rates of HIV-1 viral load monitoring in Canada: insights and implications for antiretroviral care in high income countries,” BMC Infectious Diseases, vol. 10, article 40, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. R. L. Hamers, P. W. Smit, W. Stevens, R. Schuurman, and T. F. Rinke de Wit, “Dried fluid spots for HIV type-1 viral load and resistance genotyping: a systematic review,” Antiviral Therapy, vol. 14, no. 5, pp. 619–629, 2009. View at Google Scholar · View at Scopus
  6. S. Wang, F. Xu, and U. Demirci, “Advances in developing HIV-1 viral load assays for resource-limited settings,” Biotechnology Advances, vol. 28, no. 6, pp. 770–781, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. M. Monleau, A. F. Aghokeng, S. Eymard-Duvernay et al., “Field evaluation of dried blood spots for routine HIV-1 viral load and drug resistance monitoring in patients receiving antiretroviral therapy in Africa and Asia,” Journal of Clinical Microbiology, vol. 52, no. 2, pp. 578–586, 2014. View at Publisher · View at Google Scholar · View at Scopus
  8. J. Gerlach, M. Sequeira, V. Alvarado et al., “Cost analysis of centralized viral load testing for antiretroviral therapy monitoring in Nicaragua, a low-HIV prevalence, low-resource setting,” Journal of the International AIDS Society, vol. 13, no. 1, article 43, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. Z. Zhou, N. Wagar, J. R. DeVos et al., “Optimization of a low cost and broadly sensitive genotyping assay for HIV-1 drug resistance surveillance and monitoring in resource-limited settings,” PLoS ONE, vol. 6, no. 11, Article ID e28184, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. K. Tamura, G. Stecher, D. Peterson, A. Filipski, and S. Kumar, “MEGA6: molecular evolutionary genetics analysis version 6.0,” Molecular Biology and Evolution, vol. 30, no. 12, pp. 2725–2729, 2013. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Andreotti, M. Pirillo, G. Guidotti et al., “Correlation between HIV-1 viral load quantification in plasma, dried blood spots, and dried plasma spots using the Roche COBAS Taqman assay,” Journal of Clinical Virology, vol. 47, no. 1, pp. 4–7, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. UNAIDS and WHO, “UNAIDS Report on the Global Aids Epidemic 2012,” 2012.
  13. J. G. García-Lerma, A. McNulty, C. Jennings, D. Huang, W. Heneine, and J. W. Bremer, “Rapid decline in the efficiency of HIV drug resistance genotyping from dried blood spots (DBS) and dried plasma spots (DPS) stored at 37°C and high humidity,” Journal of Antimicrobial Chemotherapy, vol. 64, no. 1, pp. 33–36, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. M. Monleau, C. Butel, E. Delaporte, F. Boillot, and M. Peeters, “Effect of storage conditions of dried plasma and blood spots on HIV-1 RNA quantification and PCR amplification for drug resistance genotyping,” Journal of Antimicrobial Chemotherapy, vol. 65, no. 8, Article ID dkq205, pp. 1562–1566, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. R. Lira, H. Valdez-Salazar, G. Vazquez-Rosales et al., “Genotypic testing for HIV-1 drug resistance using dried blood samples,” Archives of Virology, vol. 155, no. 7, pp. 1117–1125, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. S. Inzaule, C. Yang, A. Kasembeli et al., “Field evaluation of a broadly sensitive HIV-1 In-house genotyping assay for use with both plasma and dried blood spot specimens in a resource-limited country,” Journal of Clinical Microbiology, vol. 51, no. 2, pp. 529–539, 2013. View at Publisher · View at Google Scholar · View at Scopus
  17. J. J. G. van Oosterhout, L. Brown, R. Weigel et al., “Diagnosis of antiretroviral therapy failure in Malawi: poor performance of clinical and immunological WHO criteria,” Tropical Medicine and International Health, vol. 14, no. 8, pp. 856–861, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. P. Mee, K. L. Fielding, S. Charalambous, G. J. Churchyard, and A. D. Grant, “Evaluation of the WHO criteria for antiretroviral treatment failure among adults in South Africa,” AIDS, vol. 22, no. 15, pp. 1971–1977, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. M. T. Alvarez-Muñoz, S. Zaragoza-Rodríguez, O. Rojas-Montes et al., “High correlation of human immunodeficiency virus type-1 viral load measured in dried-blood spot samples and in plasma under different storage conditions,” Archives of Medical Research, vol. 36, no. 4, pp. 382–386, 2005. View at Publisher · View at Google Scholar · View at Scopus
  20. B. Amellal, C. Katlama, and V. Calvez, “Evaluation of the use of dried spots and of different storage conditions of plasma for HIV-1 RNA quantification,” HIV Medicine, vol. 8, no. 6, pp. 396–400, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. D. Brambilla, C. Jennings, G. Aldrovandi et al., “Multicenter evaluation of use of dried blood and plasma spot specimens in quantitative assays for human immunodeficiency virus RNA: measurement, precision, and RNA stability,” Journal of Clinical Microbiology, vol. 41, no. 5, pp. 1888–1893, 2003. View at Publisher · View at Google Scholar · View at Scopus
  22. C. Garrido, N. Zahonero, A. Corral, M. Arredondo, V. Soriano, and C. de Mendoza, “Correlation between human immunodeficiency virus type 1 (HIV-1) RNA measurements obtained with dried blood spots and those obtained with plasma by use of Nuclisens EasyQ HIV-1 and Abbott RealTime HIV load tests,” Journal of Clinical Microbiology, vol. 47, no. 4, pp. 1031–1036, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. A. Johannessen, M. Trøseid, and A. Calmy, “Dried blood spots can expand access to virological monitoring of HIV treatment in resource-limited settings,” Journal of Antimicrobial Chemotherapy, vol. 64, no. 6, Article ID dkp353, pp. 1126–1129, 2009. View at Publisher · View at Google Scholar · View at Scopus
  24. A. Johannessen, “Dried blood spots in HIV monitoring: applications in resource-limited settings,” Bioanalysis, vol. 2, no. 11, pp. 1893–1908, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. A. D. Mbida, S. Sosso, P. Flori et al., “Measure of viral load by using the Abbott Real-Time HIV-1 assay on dried blood and plasma spot specimens collected in 2 rural dispensaries in Cameroon,” Journal of Acquired Immune Deficiency Syndromes, vol. 52, no. 1, pp. 9–16, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. S. Reigadas, M. H. Schrive, V. Aurillac-Lavignolle, and H. J. Fleury, “Quantitation of HIV-1 RNA in dried blood and plasma spots,” Journal of Virological Methods, vol. 161, no. 1, pp. 177–180, 2009. View at Publisher · View at Google Scholar · View at Scopus
  27. K. Steegen, S. Luchters, E. Demecheleer et al., “Feasibility of detecting human immunodeficiency virus type 1 drug resistance in DNA extracted from whole blood or dried blood spots,” Journal of Clinical Microbiology, vol. 45, no. 10, pp. 3342–3351, 2007. View at Publisher · View at Google Scholar · View at Scopus
  28. C. Yang, A. McNulty, K. Diallo et al., “Development and application of a broadly sensitive dried-blood-spot-based genotyping assay for global surveillance of HIV-1 drug resistance,” Journal of Clinical Microbiology, vol. 48, no. 9, pp. 3158–3164, 2010. View at Publisher · View at Google Scholar · View at Scopus
  29. A. S. Youngpairoj, S. Masciotra, C. Garrido, N. Zahonero, C. de Mendoza, and J. G. García-Lerma, “HIV-1 drug resistance genotyping from dried blood spots stored for 1 year at 4°C,” Journal of Antimicrobial Chemotherapy, vol. 61, no. 6, pp. 1217–1220, 2008. View at Publisher · View at Google Scholar · View at Scopus
  30. A. Johannessen, C. Garrido, N. Zahonero et al., “Dried blood spots perform well in viral load monitoring of patients who receive antiretroviral treatment in rural Tanzania,” Clinical Infectious Diseases, vol. 49, no. 6, pp. 976–981, 2009. View at Publisher · View at Google Scholar · View at Scopus
  31. A. Akane, K. Matsubara, H. Nakamura, S. Takahashi, and K. Kimura, “Identification of the heme compound copurified with deoxyribonucleic acid (DNA) from bloodstains, a major inhibitor of polymerase chain reaction (PCR) amplification,” Journal of Forensic Sciences, vol. 39, no. 2, pp. 362–372, 1994. View at Google Scholar · View at Scopus
  32. X. Bi, H. Gatanaga, S. Ida et al., “Emergence of protease inhibitor resistance-associated mutations in plasma HIV-1 precedes that in proviruses of peripheral blood mononuclear cells by more than a year,” Journal of Acquired Immune Deficiency Syndromes, vol. 34, no. 1, pp. 1–6, 2003. View at Publisher · View at Google Scholar · View at Scopus
  33. WHO, Rapid Advice: Antiretroviral Therapy for HIV Infection in Adults and Adolescents, World Health Organization, Geneva, Switzerland, 2009.
  34. S. Cassol, M. J. Gill, R. Pilon et al., “Quantification of human immunodeficiency virus type 1 RNA from dried plasma spots collected on filter paper,” Journal of Clinical Microbiology, vol. 35, no. 11, pp. 2795–2801, 1997. View at Google Scholar · View at Scopus
  35. A. C. Hearps, C. E. Ryan, L. M. Morris, M. M. Plate, V. Greengrass, and S. M. Crowe, “Stability of dried blood spots for HIV-1 drug resistance analysis,” Current HIV Research, vol. 8, no. 2, pp. 134–140, 2010. View at Publisher · View at Google Scholar · View at Scopus
  36. A. McNulty, C. Jennings, D. Bennett et al., “Evaluation of dried blood spots for human immunodeficiency virus type 1 drug resistance testing,” Journal of Clinical Microbiology, vol. 45, no. 2, pp. 517–521, 2007. View at Publisher · View at Google Scholar · View at Scopus
  37. R. Dachraoui, A. Depatureaux, M. Chakroun et al., “Monitoring of HIV-1 resistance in Tunisia (North Africa) with a dried plasma spot strategy,” Journal of Acquired Immune Deficiency Syndromes, vol. 47, no. 4, pp. 522–525, 2008. View at Publisher · View at Google Scholar · View at Scopus
  38. R. Hallack, L. E. Doherty, J. A. Wethers, and M. M. Parker, “Evaluation of dried blood spot specimens for HIV-1 drug-resistance testing using the Trugene HIV-1 genotyping assay,” Journal of Clinical Virology, vol. 41, no. 4, pp. 283–287, 2008. View at Publisher · View at Google Scholar · View at Scopus
  39. S. Masciotra, C. Garrido, A. S. Youngpairoj et al., “High concordance between HIV-1 drug resistance genotypes generated from plasma and dried blood spots in antiretroviral-experienced patients,” AIDS, vol. 21, no. 18, pp. 2503–2511, 2007. View at Publisher · View at Google Scholar · View at Scopus
  40. S. Bertagnolio, L. Soto-Ramirez, R. Pilon et al., “HIV-1 drug resistance surveillance using dried whole blood spots,” Antiviral Therapy, vol. 12, no. 1, pp. 107–113, 2007. View at Google Scholar · View at Scopus